![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessDYRK2 downregulation in colorectal cancer leads to epithelial–mesenchymal transition induction and chemoresistance
Colorectal cancer (CRC) is among the most prominent causes of cancer-associated mortality in the world, with chemoresistance representing one of the leading causes of treatment failure. However, the mechanisms...
-
Article
Open AccessCorrection to: Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms
-
Article
Open AccessHomologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms
No prominent advancements in osteosarcoma (OS) treatment have been made in the past 20 years. Although photodynamic therapy (PDT) is an emerging technique for cancer therapy, the lack of targeted photosensitiz...
-
Article
Open AccessRhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway
Osteosarcoma (OS) is the most prevalent primary bone malignancy affecting adolescents, yet the emergence of chemoradiotherapeutic resistance has limited efforts to cure affected patients to date. Pyropheophorb...